This compound is a peptide synthesis intermediate featuring a fluorenylmethoxycarbonyl (Fmoc) protecting group and a dihydroorotamide-modified phenylalanine residue. It is primarily used in the research and manufacturing of specialized peptides.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1253282-31-3
Fmoc-D-Arg-OH
Peptide synthesis intermediate
L-Ornithine, N2-[(1,1-dimethylethoxy)carbonyl]-N5-[imino[[(4-methylphenyl)sulfonyl]amino]methyl]-
Peptide synthesis intermediate
Boc-His(Trt)-Gly-OH
Peptide synthesis intermediate
Fmoc-His-Aib-OH
Peptide synthesis intermediate
(S)-1,1,1-trifluoropropan-2-amine hydrochloride
Pharmaceutical intermediate
3-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline
pharmaceutical intermediate
Benzyl 4-(oxetan-3-yl) piperazine-1-carboxylate
Pharmaceutical intermediate for drug synthesis
Benzamide, N-(1,2-dihydro-1-(6-(hydroxymethyl)-4-(triphenylmethyl)-2-morpholinyl)-2-oxo-4-pyrimidinyl)-, (2R-cis)-
Morpholino cytosine monomer intermediate
(2S)-3-[4-[[(4S)-2,6-dioxo-1,3-diazinane-4-carbonyl]amino]phenyl]-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid
TYZSMQUWFLKJFB-ZEQRLZLVSA-N
C1[C@H](NC(=O)NC1=O)C(=O)NC2=CC=C(C=C2)C[C@@H](C(=O)O)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35